|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$50,825.43 |
2.40% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$45,526.50 |
2.15% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$45,292.58 |
2.14% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$45,215.44 |
2.14% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$44,698.28 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$44,463.92 |
2.10% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$44,213.76 |
2.09% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,250.53 |
2.09% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$43,932.97 |
2.08% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$43,914.68 |
2.08% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$43,914.45 |
2.08% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$44,057.94 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,580.11 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$43,510.00 |
2.06% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$43,375.63 |
2.05% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$43,224.76 |
2.04% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$43,170.34 |
2.04% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$43,041.96 |
2.04% |
| Waters Corporation |
WAT |
941848103 |
120 |
$43,140.00 |
2.04% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$42,861.57 |
2.03% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$42,946.08 |
2.03% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$42,856.33 |
2.03% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$42,422.03 |
2.01% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$42,423.99 |
2.01% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$42,475.28 |
2.01% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$42,263.98 |
2.00% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$42,075.94 |
1.99% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$42,003.89 |
1.99% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$41,827.34 |
1.98% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,783.70 |
1.98% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$41,559.30 |
1.97% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$41,729.98 |
1.97% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$41,615.11 |
1.97% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$41,215.98 |
1.95% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$41,017.90 |
1.94% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,016.35 |
1.94% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$40,755.57 |
1.93% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$40,787.28 |
1.93% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$40,728.54 |
1.93% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$40,628.72 |
1.92% |
| Steris Plc |
STE |
G8473T100 |
169 |
$40,688.44 |
1.92% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$39,767.62 |
1.88% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$39,540.73 |
1.87% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$39,517.33 |
1.87% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$39,608.92 |
1.87% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$39,154.06 |
1.85% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$38,707.47 |
1.83% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,181.85 |
1.81% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$38,145.03 |
1.80% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$38,093.93 |
1.80% |
| US Dollar |
$USD |
|
3,074 |
$3,074.00 |
0.15% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|